What the CDMO cell and gene therapy landscape tells us about the future of validation
Validation requirements are different for CDMOs in Cell and Gene Therapy development — but there are ways to make it....
Resources
Resource center
Subscribe for updates
Featured
Resources
Navigating 21 CFR Part 11
All companies under the FDA scope must navigate 21 CFR Part 11 for data integrity.
What is data integrity?
Ensure you stay compliant by understanding what data integrity is and the best practices to stay on the right side....
The evolving landscape of validation programs in 2024
Explore key trends in validation programs from the 2024 State of Validation Report.
Insights from the 2024 state of validation report: people and organizations
Read this article to discover key findings from the 2024 State of Validation Report, including trends in team sizes, outsourcing,....
Paperless validation
Read our blog to discover the benefits of paperless validation, streamlining operations and promoting sustainability.
ALCOA ++: data integrity and ALCOA
Learn what you need to know about the new ALCOA ++
VALIDATE 2024: digitalization and change in validation
Read this article to explore the key highlights and insights from the VALIDATE 2024 conference, focusing on change management, validation....
Life sciences software: risks and reward of new technology
Onboarding new software into life sciences manufacturing isn’t an easy exercise, but it's worth it. We explain life sciences software....